{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:05:36Z","timestamp":1766073936944,"version":"3.48.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Congenital toxoplasmosis (CT) can cause significant neurologic manifestations and other untoward sequelae. Neither the current epidemiology nor the disease severity of CT in Israel is known.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Records of CT were collected from the National Toxoplasmosis Reference Laboratory and from 15 medical centers across Israel between 2001 and 2017. Eligible case-patients were fetuses or infants &lt;12 months of age at the time of diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 43 CT cases identified, 24 (55%) were in Jews and the remaining 19 cases were in patients of Arab (non-Bedouin) origin. The overall annual estimated rate of symptomatic CT was calculated as 0.55 per 100,000 live births. One or more severe clinical manifestations were reported in 12 (46%) of the 28 live-born infants and included cerebral calcifications (7 cases), chorioretinitis (4 cases), hydrocephalus (2 cases) and 1 case of death. Sensitivities of blood polymerase chain reaction (PCR), cerebrospinal fluid PCR and IgM antibody tests were 50% each. However, analyzing PCR samples from both sites, together with IgM testing, increased the sensitivity to 93%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The relative rate of severe manifestations was higher than in previous European reports. It is possible that the greater disease severity observed in Israel is in part due to the lack of systematic antenatal treatment and screening. Arab (non-Bedouin) infants are at higher risk for contracting CT. Performing serologic and PCR tests simultaneously is essential to improve CT diagnosis. This study demonstrates a need for an educational program to target high-risk populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000002598","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T04:45:31Z","timestamp":1589258731000},"page":"553-559","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Characterization of Congenital Toxoplasmosis in Israel"],"prefix":"10.1097","volume":"39","author":[{"given":"Yaara","family":"Kahan","sequence":"first","affiliation":[{"name":"Pediatric Infectious disease unit, E.Wolfson Medical center, Holon, Israel"},{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Avidar","sequence":"additional","affiliation":[{"name":"Pediatric Infectious disease unit, E.Wolfson Medical center, Holon, Israel"},{"name":"Department of Pediatrics, Mayanei Hayeshua Medical Center, Bnei Brak, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bat-Sheva","family":"Gottesman","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Israel"},{"name":"Infectious Diseases Unit, Meir Medical Centre, Kfar-Saba, Israel"},{"name":"Department of Family Medicine, Sharon-Shomron District, Clalit Health Services"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Riklis","sequence":"additional","affiliation":[{"name":"National Public Health Laboratory, Israel Ministry of Health, Tel Aviv, Israel"},{"name":"National Toxoplasmosis Reference Laboratory, Israel Ministry of Health, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeev","family":"Dveyrin","sequence":"additional","affiliation":[{"name":"National Toxoplasmosis Reference Laboratory, Israel Ministry of Health, Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Dalal","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, E. Wolfson Medical Center, Holon, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Meir","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Unit, The Ruth Rappaport Children\u2019s Hospital Rambam Health Care Campus, Haifa, Israel"},{"name":"Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Glikman","sequence":"additional","affiliation":[{"name":"The Azrieli Faculty of Medicine in the Galilee, Bar Ilan university, Safed, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efraim","family":"Bilavsky","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Israel"},{"name":"Department of Pediatrics C, Schneider Children\u2019s Medical Center, Petah Tiqva, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilad","family":"Sherman","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Israel"},{"name":"Pediatric infectious diseases unit, Sheba medical center, Tel-Hashomer, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shereen","family":"Shehadeh","sequence":"additional","affiliation":[{"name":"Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel"},{"name":"Department of Pediatrics, Carmel Medical Center, Haifa, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Tasher","sequence":"additional","affiliation":[{"name":"Pediatric Infectious disease unit, E.Wolfson Medical center, Holon, Israel"},{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for Israeli Congenital Toxoplasmosis Research Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251218","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/bmj.321.7254.142","article-title":"Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis.","volume":"321","author":"Cook","year":"2000","journal-title":"BMJ"},{"key":"R2-20251218","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/INF.0b013e3182343096","article-title":"Severe congenital toxoplasmosis in the United States: clinical and serologic findings in untreated infants.","volume":"30","author":"Olariu","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R3-20251218","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1542\/peds.66.5.767","article-title":"Development of adverse sequelae in children born with subclinical congenital toxoplasma infection.","volume":"66","author":"Wilson","year":"1980","journal-title":"Pediatrics"},{"key":"R4-20251218","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.respe.2009.03.006","article-title":"Toxoplasmosis among pregnant women in France: risk factors and change of prevalence between 1995 and 2003.","volume":"57","author":"Berger","year":"2009","journal-title":"Rev Epidemiol Sante Publique"},{"key":"R5-20251218","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","article-title":"Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis.","volume":"39","author":"Pappas","year":"2009","journal-title":"Int J Parasitol"},{"key":"R6-20251218","doi-asserted-by":"crossref","first-page":"e20163860","DOI":"10.1542\/peds.2016-3860","article-title":"Diagnosis, treatment, and prevention of congenital toxoplasmosis in the United States.","volume":"139","author":"Maldonado","year":"2017","journal-title":"Pediatrics"},{"key":"R7-20251218","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis.","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"R8-20251218","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1590\/S0074-02762009000200037","article-title":"Prevalence of acute toxoplasmosis infection among 41,112 pregnant women and the mother-to-child transmission rate in a public hospital in South Brazil.","volume":"104","author":"Varella","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"R9-20251218","doi-asserted-by":"crossref","first-page":"e0005222","DOI":"10.1371\/journal.pntd.0005222","article-title":"Congenital toxoplasmosis in France and the United States: one parasite, two diverging approaches.","volume":"11","author":"Peyron","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"R10-20251218","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/adc.2004.066514","article-title":"The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002.","volume":"91","author":"Schmidt","year":"2006","journal-title":"Arch Dis Child"},{"issue":"suppl 1","key":"R12-20251218","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1086\/338827","article-title":"Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis.","volume":"185","author":"Montoya","year":"2002","journal-title":"J Infect Dis"},{"key":"R13-20251218","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1128\/JCM.02900-14","article-title":"A 10-year retrospective comparison of two target sequences, REP-529 and B1, for Toxoplasma gondii detection by quantitative PCR.","volume":"53","author":"Belaz","year":"2015","journal-title":"J Clin Microbiol"},{"key":"R15-20251218","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1186\/1471-2458-12-1019","article-title":"A dedicated surveillance network for congenital toxoplasmosis in Greece, 2006-2009: assessment of the results.","volume":"12","author":"Aptouramani","year":"2012","journal-title":"BMC Public Health"},{"key":"R16-20251218","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/adc.2005.088385","article-title":"Symptomatic toxoplasma infection due to congenital and postnatally acquired infection.","volume":"91","author":"Gilbert","year":"2006","journal-title":"Arch Dis Child"},{"key":"R17-20251218","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1017\/S0950268813000903","article-title":"Seroepidemiology of Toxoplasma gondii infection in the Israeli population.","volume":"142","author":"Markovich","year":"2014","journal-title":"Epidemiol Infect"},{"key":"R18-20251218","first-page":"636","article-title":"Seroprevalence of antibodies against Toxoplasma gondii among two rural populations in northern Israel.","volume":"29","author":"Raz","year":"1993","journal-title":"Isr J Med Sci"},{"key":"R19-20251218","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1086\/605433","article-title":"Risk factors for Toxoplasma gondii infection in the United States.","volume":"49","author":"Jones","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R20-20251218","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0140-6736(07)60072-5","article-title":"Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients\u2019 data.","volume":"369","year":"2007","journal-title":"Lancet"},{"key":"R21-20251218","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/cid\/cit032","article-title":"Congenital toxoplasma infection: monthly prenatal screening decreases transmission rate and improves clinical outcome at age 3 years.","volume":"56","author":"Wallon","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R22-20251218","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/cid\/cis258","article-title":"Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009).","volume":"54","author":"McLeod","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R23-20251218","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1371\/journal.pntd.0000277","article-title":"Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe.","volume":"2","author":"Gilbert","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"R24-20251218","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1098\/rstb.2009.0087","article-title":"Genetic diversity of Toxoplasma gondii in animals and humans.","volume":"364","author":"David Sibley","year":"2009","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"R25-20251218","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1017\/S0031182015000050","article-title":"Genetic characterization of Toxoplasma gondii isolates from Portugal, Austria and Israel reveals higher genetic variability within the type II lineage.","volume":"142","author":"Verma","year":"2015","journal-title":"Parasitology"},{"key":"R26-20251218","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4269\/ajtmh.2008.79.205","article-title":"Prevalent genotypes of Toxoplasma gondii in pregnant women and patients from Crete and Cyprus.","volume":"79","author":"Messaritakis","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"R27-20251218","first-page":"1","article-title":"A review of toxoplasmosis in humans and animals in Turkey.","author":"Kol\u00f6ren","year":"2019","journal-title":"Parasitology"},{"key":"R28-20251218","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12639-018-1029-4","article-title":"Seroprevalence, isolation, molecular detection and genetic diversity of Toxoplasma gondii from small ruminants in Egypt.","volume":"42","author":"Abd El-Razik","year":"2018","journal-title":"J Parasit Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:01:27Z","timestamp":1766073687000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002598"}},"subtitle":["A 17-year Nationwide Study Experience"],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002598","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}